NYSE:JCAP - New York Stock Exchange, Inc. -
Jernigan Capital (JCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / October 1, 2020 / In an ever-changing global market with instability across the world in 2020, the Real Estate Market has shown to make leaps and bounds. Record low interest rates in the United States following the COVID-19 pandemic have created an influx of demand for property in Florida, forcing Real Estate Professionals to adapt in numerous ways. Developing new marketing strategies, finding new ways to
Mentions: VAR
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: GCI Liberty, Inc. (NASDAQ:GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Liberty Broadband Corporation. To learn more about your legal rights and options, visit:
Mentions: CGIX
NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit:
NEW YORK, NY / ACCESSWIRE / August 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit:
New York, NY / ACCESSWIRE / August 14, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Jernigan Capital, Inc. (NYSE: JCAP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to an affiliate of NexPoint Advisors, L.P. Under the terms of the agreement, Jernigan Capital common stockholders will receive $17.30 per share in cash. To learn more about
NEW YORK, NY / ACCESSWIRE / August 11, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit:
NEW YORK, NY / ACCESSWIRE / August 8, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit:
Jernigan Capital 7.0% CUM PFD B (NYSE:JCAP.PB) declares $0.4375/share quarterly dividend, in line with previous.Forward yield 6.96%Payable Oct.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - JCAP, IFF, NGHC, ADSW NEW YORK, NY / ACCESSWIRE / August 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Jernigan Capital, Inc. (NYSE:JCAP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to an
Gainers Marathon Patent Group, Inc. (NASDAQ: MARA) shares surged 88.7% to close at $3.83 on Monday. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders...
NEW YORK, NY / ACCESSWIRE / August 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE:VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit: